COVID update – Plagues, current and future COVID-19
COVID – 5th dose, flu – concurrent annual booster, many recrudescent diseases
Practical migraine management tips
Sub-optimal treatment has led many patients to incorrectly think little can be done
Sleep monitoring and wearables
Apart from its use in assessing sleep, one can imagine how such devices may in time come to, stream real time data of our most at risk patients when something has gone awry
7 key questions to assess depression risk in the clinic
A psychiatrist reveals questions he asks to assess vulnerability to stress and depression
Pelvic floor dysfunction in frail elderly women
The range of treatments available for pelvic floor dysfunction in the frail elderly, and how this differs from an older patient who is otherwise in good health
Integrated prosthetics and reconstruction – 3D printing and virtual surgical planning after cancer surgery
Virtual planning for head and neck reconstruction, a comprehensive multi-disciplinary task that is highly detailed to create prosthetics to exacting standards and precision
Glaucoma – Diagnosis and treatment
The types of traditional and novel treatments for glaucoma
What are you prescribing for atrial fibrillation?
Despite widespread uptake, DOACs are still underutilised and atrial fibrillation is still undertreated in Australia
Travel medicine
With many Australians taking advantage of open borders this summer holiday, Dr Deb Mills, Travel Medicine Expert, helps unpack some information on travel vaccinations, and also provides an update on rabies, and the precautions vacationers should take to minimise their risk
A Guide to Testosterone for Menopausal Women
New pneumococcal 15-valent conjugate vaccine that includes coverage against serotype 3
In this Product Explainer, Public Health Physician and Infectious Diseases Epidemiologist Prof Paul Van Buynder explains the burden of pneumococcal disease in both children and adult population. He explains why PCV 15 has increased serotype coverage and why improved immunogenicity against serotype 3 is important both from a clinical and public health perspective (6 mins).
